CStone Pharmaceuticals (Suzhou) Co. Ltd – Trademark Portfolio

Entity Type: 99

CStone Pharmaceuticals (Suzhou) Co. Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include FAYAGO and CEJEMLY. The owner is based in Suzhou.

E168, 2nd fl, A1 North, Xinghu St. 218

Suzhou Industrial Park, Wuzhong Dist.

Suzhou 215123 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CEJEMLY
CEJEMLY
Registered 2019
FAYAGO
FAYAGO
Registered 2019

Trademark Classifications

CStone Pharmaceuticals (Suzhou) Co. Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CStone Pharmaceuticals (Suzhou) Co. Ltd have?

CStone Pharmaceuticals (Suzhou) Co. Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does CStone Pharmaceuticals (Suzhou) Co. Ltd file in?

CStone Pharmaceuticals (Suzhou) Co. Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CStone Pharmaceuticals (Suzhou) Co. Ltd's most well-known trademarks?

CStone Pharmaceuticals (Suzhou) Co. Ltd's registered trademark portfolio includes well-known marks such as FAYAGO and CEJEMLY. These are among 2 currently registered trademarks in the portfolio.

What is CStone Pharmaceuticals (Suzhou) Co. Ltd's trademark registration success rate?

CStone Pharmaceuticals (Suzhou) Co. Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.